NNAG welcomes the appointment of the new NHS England and NHS Improvement National Clinical Directors for Neurology, and Neurosurgery and Spinal Surgery. In light of changes to the national leadership and clinical reference groups, as well the new commissioning structure, NNAG members agreed to wind down the activities and meetings of this group at the end of 2022. The neuroscience community will continue to work together for a brigher future for people affected by neurological conditions.
The website and publications will continue to be available for use. For all enquiries, please contact the Neurological Alliance.
NNAG Core Group
The NNAG core group is responsible for the strategic direction of our work. Members of the Core group represent professional bodies, patient organisations and national neurosciences programmes and speciality areas.
Co-Chairs
Professor Adrian Williams
Consultant Neurologist, Chair of the NHS England and NHS Improvement Neuroscience Clinical Reference Group
Georgina Carr
Chief Executive, Neurological Alliance
Members:
Dr Catherine Mummery
Chair of Services Committee, Association of British Neurologists
Mr Alistair Jenkins
President, The Society of British Neurological Surgeons
Debbie Quinn
Neuroscience Forum Chair, Royal College of Nursing
Dr Jacquie Deeb
President, British Society for Clinical Neurophysiologists
Professor David Burn
President, Association of British Neurologists
Dr Nick Kane
President, Joint Neurosciences Council
Dr Geraint Fuller
Clinical Lead, Neurology GIRFT, NHS England and NHS Improvement
Jodie Powell
National Stroke Programme Lead, Clinical Policy Unit, NHS England and NHS Improvement
Priya Oomahdat
National Head of Neurosurgery and Specialised Neurology Transformation Specialised Commissioning, NHS England and NHS Improvement
Mr Nick Phillips
Clinical lead, Cranial Neurosurgery GIRFT, NHS England and Improvement
Sarah Marsh
Head of Clinical Policy and Programmes, Clinical Policy Unit, NHS England and NHS Improvement
Michael Jackson
Head of Health Intelligence (Dementia & Neurology), Health Intelligence Division, Public Health England
Chris James
Director of External Affairs, Motor Neurone Disease Association.
Co-Chair of the Patient Group Forum
Sammy Ashby
Deputy Chief Executive, SUDEP Action,
Co-Chair of the Patient Group Forum
Julie Riley
Divisional Director Neurology, The Walton Centre NHS Foundation Trust
Dr Mike Dilley
Consultant Neuropsychiatrist, St Georges University Hospitals NHS Foundation Trust
Shelley Jones
Chair, UK Clinical Pharmacy Association Neurosciences Group
Dr Susan Mitchell
Head of Policy, Alzheimers Research UK (representing Dementia Access Taskforce)
Nick Moberly
Chief Executive, MS Society
Professor Nick Wood
Research Director of the UCL Institute of Genetics, UCL
Professor Peter Hutchinson
Professor of Neurosurgery at the University of Cambridge and Director of Clinical Research at the Royal College of Surgeons of England
Hannah Verghese
Programme Manager, National Neurosciences Advisory Group
Dr Helen Grote
Consultant Neurologist, Chelsea and Westminster Hospital NHS Foundation Trust
Dr Martin Wilson
Specialist Clinical Adviser to the Specialised Neurology Transformation Programme, NHS England and NHS Improvement
Dr Jon Sussmann
Specialist Clinical Adviser to the Specialised Neurology Transformation Programme, NHS England and NHS Improvement